WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001029057) ANTISENSE MODULATION OF BCL-6 EXPRESSION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/029057    International Application No.:    PCT/US2000/027963
Publication Date: 26.04.2001 International Filing Date: 11.10.2000
Chapter 2 Demand Filed:    10.05.2001    
IPC:
A61K 38/00 (2006.01), C07H 21/00 (2006.01), C12N 15/11 (2006.01)
Applicants: ISIS PHARMACEUTICALS, INC. [US/US]; 2292 Faraday Avenue, Carlsbad, CA 92008 (US) (For All Designated States Except US).
TAYLOR, Jennifer, K. [US/US]; (US) (For US Only).
COWSERT, Lex, M. [US/US]; (US) (For US Only)
Inventors: TAYLOR, Jennifer, K.; (US).
COWSERT, Lex, M.; (US)
Agent: LICATA, Jane, Massey; Law Offices of Jane Massey Licata, 66 E. Main Street, Marlton, NJ 08053 (US)
Priority Data:
09/418,640 15.10.1999 US
Title (EN) ANTISENSE MODULATION OF BCL-6 EXPRESSION
(FR) MODULATION ANTISENS DE L'EXPRESSION DE BCL-6
Abstract: front page image
(EN)Antisense compounds, compositions and methods are provided for modulating the expression of bcl-6. The compositions comprise antisense coumpounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding bcl-6. Methods of using these compounds for modulation of bcl-6 expression and for treatment of diseases associated with expression of bcl-6 are provided.
(FR)La présente invention concerne des composés antisens, des compositions et des procédés permettant de moduler l'expression de bcl-6. Ces compositions comprennent des composés antisens, en particulier des oligonucléotides antisens, ciblés sur des acides nucléiques codant bcl-6. L'invention concerne également des procédés permettant d'utiliser ces composés pour moduler l'expression de bcl-6, ainsi que pour le traitement d'affections associées à l'expression de bcl-6.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)